Integra Lifesciences Prices $450M Senior Secured Notes at 9.500%

By Philip Seaworth • Saturday, October 10 16:08 • Permanent Link

Integra Lifesciences Holdings priced $450 million of senior secured notes due 2033 at 9.500%, adding a new layer to a refinancing package aimed at replacing its existing credit facilities.

The company said the notes are expected to close on or about October 19, 2026. The debt will be issued as general senior secured obligations and guaranteed by Integra’s wholly owned domestic subsidiaries that already back its senior secured credit facilities.

The offering is being used alongside borrowings from a new credit facility to refinance existing debt and cover related fees and expenses. In dollar terms, the new notes total $450 million of principal, and the company has set the coupon at 9.500% through 2033. The market has reacted to these announcements by moving the company's shares 3.15% to a price of $13.41. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.